Clinical study

PSI is performing a clinical study with affiliate SouthShore Biopharma titled "Efficacy of Cannabis for Reducing Opioid Requirements in Severe Pain Conditions". 

Medical outcome assessment tool

PSI is committed to systematically assessing the therapeutic efficacy of medical cannabis and hemp. To this end, PSI has developed a powerful mobile application that can be used to longitudinally assess the effects of specific products. Using a set of methodical questionnaires we can evaluate the effects of medical cannabis and hemp products on the wellbeing and medical conditions of patients and customers. The tool is particularly effective in tracking levels of opioid addiction and chronic pain. PSI is presently utilizing the Medical Outcomes Assessment Tool in clinical trials, at dispensaries, and as a method of collecting marketing data from retailers. 

WHITE PAPER

In 2016, PSI authored a white paper titled "Cannabis Testing for Public Safety – Best Practices for Vermont Analytical Laboratories” to aid the Vermont legislature in developing rules and regulations for ensuring the safety of the state’s medical cannabis program.

CANNABIS COURSE & Speaker series

The PSI team helped to develop a medical cannabis course at The University of Vermont College of Medicine. It is the first of its kind to be offered by an accredited medical school. The rigorous program addresses the increasing need for research-based, and relevant medical Cannabis education across the country.

The team also helped to establish the first and only Cannabis Science and Medicine Professional Certificate in the US. Designed for physicians, dispensary personnel, nurse practitioners, pharmacists, physician assistants, edible creators, regulators, and budtenders, the program is broad in scope. It covers cannabis history, business, law and policy, plant biology, biological effects on humans, production and safety, pharmacology, and clinical research.

To further our mission of bringing research-based education to the general public, PSI also sponsored a Cannabis Speaker Series at the University of Vermont College of Medicine.